115 related articles for article (PubMed ID: 20378382)
21. Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis.
Raza K; Mathsson L; Buckley CD; Filer A; Rönnelid J
Ann Rheum Dis; 2010 Mar; 69(3):627-8. PubMed ID: 19846408
[No Abstract] [Full Text] [Related]
22. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.
Bas S; Genevay S; Meyer O; Gabay C
Rheumatology (Oxford); 2003 May; 42(5):677-80. PubMed ID: 12709545
[TBL] [Abstract][Full Text] [Related]
23. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review.
Luime JJ; Colin EM; Hazes JM; Lubberts E
Ann Rheum Dis; 2010 Feb; 69(2):337-44. PubMed ID: 19289382
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
[TBL] [Abstract][Full Text] [Related]
26. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
[TBL] [Abstract][Full Text] [Related]
27. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
28. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
[TBL] [Abstract][Full Text] [Related]
29. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.
Qin X; Deng Y; Xu J; Li TJ; Li S; Zhao JM
Rheumatol Int; 2011 Jun; 31(6):785-94. PubMed ID: 20221607
[TBL] [Abstract][Full Text] [Related]
31. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
Besada E; Nikolaisen C; Nossent H
Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
[TBL] [Abstract][Full Text] [Related]
34. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
35. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
Dubrous P; Gardet V; Hugard L
Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
[TBL] [Abstract][Full Text] [Related]
36. Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.
Matsui T; Shimada K; Tohma S
Clin Rheumatol; 2006 Jul; 25(4):610-1. PubMed ID: 16283420
[No Abstract] [Full Text] [Related]
37. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
38. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D; Verschueren P; Westhovens R; Bossuyt X
Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.
Li X; Wang Z; Yi H; Xie J; Zhu N
Clin Rheumatol; 2020 Apr; 39(4):1111-1120. PubMed ID: 31858337
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.
Dejaco C; Duftner C; Klotz W; Schirmer M; Herold M
Scand J Rheumatol; 2009; 38(1):66-7. PubMed ID: 18759163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
